Novartis AG (NVS) は上場企業です ヘルスケア セクターの 製薬 業界で事業展開. 本社所在地は Basel, スイス. 現CEOは Vasant Narasimhan.
NVS を有する IPO日 1996-11-07, 75,883 名の正社員, に上場 NYSE, 時価総額 $296.06B.
Novartis AG is a global healthcare company headquartered in Basel, Switzerland, that researches, develops, manufactures, and markets a broad portfolio of prescription medicines and healthcare products worldwide. The company operates through two primary segments: Innovative Medicines, which focuses on specialty pharmaceuticals across therapeutic areas including oncology, immunology, neuroscience, ophthalmology, cardiovascular, and respiratory diseases, and Sandoz, a leading generics and biosimilars business that produces small molecule pharmaceuticals, active pharmaceutical ingredients, and biotechnology-based products. Novartis maintains strategic partnerships and collaborations with biotechnology companies to advance its clinical pipeline and expand treatment options for patients globally.